STOCK TITAN

Legend Biotech Corporation (LEGN) Net Income by Year

LEGN NASDAQ

Legend Biotech Corporation reported a net loss of $296.8M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Legend Biotech Corporation has filed alongside them.

FY2025 annual
Net Income -$296.8M
YoY n/m
5Y CAGR n/m
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LEGN Net Income by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-F
Net Income-$296.8Mn/m-$177.0Mn/m-$518.3Mn/m-$446.3Mn/m-$403.6Mn/m-$266.4Mn/m-$101.6Mn/m-$2.8M

LEGN Net Income by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ3'256-KQ2'256-KQ1'256-KQ4'2420-FQ3'246-KQ2'246-KQ1'246-KQ4'2320-FQ3'236-KQ2'236-KQ1'236-K
Net Income-$30.8M-217.2%-$39.7Mn/m-$125.4Mn/m-$100.9Mn/m$26.3M-$125.3M-$18.2M-$59.8Mn/mN/AN/AN/A-$112.1M

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Legend Biotech Corporation financials

Frequently Asked Questions

Legend Biotech Corporation reported a net loss of $296.8M in fiscal year 2025.

Legend Biotech Corporation (LEGN) reported a $177.0M net loss in fiscal year 2024 and a $296.8M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Across the 8 fiscal years this page covers, Legend Biotech Corporation (LEGN) net income went from -$2.8M in fiscal year 2018 to -$296.8M in fiscal year 2025.

Legend Biotech Corporation (LEGN) reported -$30.8M in net income in Q4 2025. This represents a decrease of 217.2% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Legend Biotech Corporation (LEGN) reported on that line in every period on record.